View Systems' subsidiary, Sannabis received notice yesterday from Colombia’s Health Ministry of Resolution 1606 of 2020 issuing Sannabis S.A.S. a Cannabis Derivative Fabrication License. This is one of four Cannabis Licenses needed in Colombia, and the only one issued by the Ministry of Health. This license allows for export of THC and Hemp/CBD cannabis derivatives around the World.
"The Derivative Fabrication License allows Sannabis to extract cannabinoids, oils, distillates, isolates and to manufacture final products for both national and export markets," the company's team explains. "The global cannabidiol market size is expected to reach US$ 23.6 billion, expanding at a CAGR of 22.2%, according to a new study by Grand View Research. Increasing adoption of cannabidiol (CBD) infused products in various industries such as pharmaceuticals, personal care and cosmetics, and nutraceuticals along with its medical applications is expected to drive the market over the next 7 years."
Sannabis will expand a state-of-the-art production complex near their grow facilities in Cauca, Colombia’s top cannabis growing region, with a library of proven genetics.
Since export of biomass (dried flower) is prohibited by the Colombian government, Sannabis has a company in Uruguay, Campo de Violetas S.A., that can export BioMass. Earlier this year, Company President and Sannabis co-founder, John Campo, was awarded an Import Permit to the U.S. from the United States Department of Agriculture (USDA) for Cannabis from Uruguay.
“This fabrication license activates the cultivation licenses, so we should have all 4 by year-end, once we get the Seed Bank approved this month,” stated Juan Paulo Guzman, Director of Sannabis S.A.S.
John Campo, President of View Systems, Inc. and co-founder of Sannabis added, “these licenses have added incredible value to our company and allow us to work with pharmaceutical and consumer goods companies wanting to enter the Cannabis space with a licensed supplier of high-quality certified derivatives.”